4682-36-4Cc1ccccc1C(OCC[NH+](C)C)c1ccccc1.O=C([O-])CC(O)(CC(=O)O)C(=O)OMMMNTDFSPSQXJP-UHFFFAOYSA-NSee also: Orphenadrine Citrate (preferred); Orphenadrine (has active moiety); Aspirin; caffeine; orphenadrine citrate (component of).
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Usesskeletal muscle relaxant, antihistaminic agent
UsesA histaminergic compound
UsesMuscle relaxant (skeletal); antihistaminic
General DescriptionOrphenadrine citrate, N,Ndimethyl-2-(o-methyl-α-phenylbenzyloxy)ethylamine citrate(1:1) (Norflex), introduced in 1957, is closely related todiphenhydramine structurally but has much lower antihistaminicactivity and much higher anticholinergic action.Likewise, it lacks the sedative effects characteristic ofdiphenhydramine. Pharmacological testing indicates that itis not primarily a peripherally acting anticholinergic becauseit has only weak effects on smooth muscle, on the eye,and on secretory glands. It does reduce voluntary musclespasm, however, by a central inhibitory action on cerebralmotor areas, a central effect similar to that of atropine.
No reaction records under the current filter.
Loading…
4682-36-4、4724-58-7DefinitionChEBI: A citrate salt which comprises equimolar amounts of orphenadrine and citric acid.